Anthony Scott Praill - 01 Aug 2022 Form 4 Insider Report for Kintara Therapeutics, Inc. (HURA)

Role: Chief Financial Officer
Signature: /s/ Anthony Scott Praill
Issuer symbol: HURA
Transactions as of: 01 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Aug 2022, 16:30:45 UTC
Previous filing: 09 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KTRA	Common Stock	Award	$0	+240,087	+646%	$0.000000	277,273	01 Aug 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KTRA	Option (right to buy)	Award	$0	+720,260		$0.000000	720,260	01 Aug 2022	Common Stock	720,260	$0.1757	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted 240,087 restricted stock units, which will be settled in shares of the Issuer's common stock. The restricted stock units vest in 4 equal annual installments beginning on August 1, 2023.
F2	The option vests as to 25% on August 1, 2023 with the remainder to vest in 36 equal monthly installments thereafter.